110 related articles for article (PubMed ID: 4206096)
1. Editorial: Somatostatin: newcomer from the hypothalamus.
Brazeau P; Gullemin R
N Engl J Med; 1974 Apr; 290(17):963-4. PubMed ID: 4206096
[No Abstract] [Full Text] [Related]
2. Effect of somatostatin in patients with acromegaly: suppression of growth hormone, prolactin, insulin and glucose levels.
Yen SS; Siler TM; DeVane GW
N Engl J Med; 1974 Apr; 290(17):935-8. PubMed ID: 4593614
[No Abstract] [Full Text] [Related]
3. [Somatostatin--a hypothalamic factor inhibiting the secretion of growth hormone].
Lankosz-Lauterbach J
Pediatr Pol; 1977 Aug; 52(8):919-23. PubMed ID: 333364
[No Abstract] [Full Text] [Related]
4. Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.
Gerich JE; Lorenzi M; Schneider V; Karam JH; Rivier J; Guillemin R; Forsham PH
N Engl J Med; 1974 Sep; 291(11):544-7. PubMed ID: 4604408
[No Abstract] [Full Text] [Related]
5. Editorial: Growth-hormone release-inhibiting hormone.
Lancet; 1974 Jun; 1(7867):1148-50. PubMed ID: 4136663
[No Abstract] [Full Text] [Related]
6. Editorial: Somatostatin (somatotrophin release inhibiting factor).
S Afr Med J; 1974 Jun; 48(28):1180. PubMed ID: 4599981
[No Abstract] [Full Text] [Related]
7. Proceedings: Effect of growth hormone release inhibiting hormone on the release of growth hormone and other pituitary hormones in man.
Schally AV; Coy DM; Kastin AJ; Tunbridge WM; Evered DC; Weightman D; Hall R; Besser GM; Goldie DJ; McNeilly AS; Mortimer CH; Phenekos C
J Endocrinol; 1974 Apr; 61(1):XIV. PubMed ID: 4208301
[No Abstract] [Full Text] [Related]
8. [The effect of synthetic somatostatin in normal and acromegalic males].
Wiegelmann W; Solbach HG; Kley HK; Rudorff KH; Herrmann J; Zimmermann H; Krüskemper HL
Dtsch Med Wochenschr; 1975 Feb; 100(8):331-4. PubMed ID: 1090428
[TBL] [Abstract][Full Text] [Related]
9. Editorial: Somatostatin, hormone inhibitor.
Ricketts HT
JAMA; 1975 Jan; 231(4):391-2. PubMed ID: 803238
[No Abstract] [Full Text] [Related]
10. Somatostatin: a review of its effects especially in human beings.
Hansen AP; Lundbaek K
Diabete Metab; 1976 Dec; 2(4):203-18. PubMed ID: 190058
[TBL] [Abstract][Full Text] [Related]
11. Somatostatin: hypothalamic inhibitor of the endocrine pancreas.
Koerker DJ; Ruch W; Chideckel E; Palmer J; Goodner CJ; Ensinck J; Gale CC
Science; 1974 Apr; 184(4135):482-4. PubMed ID: 4594711
[TBL] [Abstract][Full Text] [Related]
12. Editorial: Diabetes, glucagon and growth hormone.
Cahill GF; Soeldner JS
N Engl J Med; 1974 Sep; 291(11):577-9. PubMed ID: 4604367
[No Abstract] [Full Text] [Related]
13. [The effects of somatostatin in acromegaly].
Schaison G; Roger M; Milhaud G
Nouv Presse Med; 1976 Mar; 5(10):629-32. PubMed ID: 772591
[TBL] [Abstract][Full Text] [Related]
14. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
[TBL] [Abstract][Full Text] [Related]
15. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients.
Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM
Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329
[TBL] [Abstract][Full Text] [Related]
16. Long-term infusion of growth hormone release inhibiting hormone in acromegaly: effects on pituitary and pancreatic hormones.
Besser GM; Mortimer CH; McNeilly AS; Thorner MO; Batistoni GA; Bloom SR; Kastrup KW; Hanssen KF; Hall R; Coy DH; Kastin AJ; Schally AV
Br Med J; 1974 Dec; 4(5945):622-7. PubMed ID: 4374289
[TBL] [Abstract][Full Text] [Related]
17. [Somatostatin--effects and possible clinical significance].
Benker G; Reinwein D
Dtsch Med Wochenschr; 1975 Apr; 100(17):961-4. PubMed ID: 164337
[No Abstract] [Full Text] [Related]
18. Regulation of growth hormone and prolactin secretion in patients with acromegaly and-or excessive prolactin secretion.
Cryer PE; Jacobs LS; Daughaday WH
Mt Sinai J Med; 1973; 40(3):402-13. PubMed ID: 4197309
[No Abstract] [Full Text] [Related]
19. Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly.
Hall R; Besser GM; Schally AV; Coy DH; Evered D; Goldie DJ; Kastin AJ; McNeilly AS; Mortimer CH; Phenekos C; Tunbridge WM; Weightman D
Lancet; 1973 Sep; 2(7829):581-4. PubMed ID: 4125377
[No Abstract] [Full Text] [Related]
20. [GH and PRL after TRH and hpGRF(1-40) administration in 2 cases of acromegaly with hyperprolactinemia].
Sampaolo G; Faloia E; Sarzani R; Bartolacci V; Schiavo P; Butini L; Morosini P
Recenti Prog Med; 1987 Mar; 78(3):115-8. PubMed ID: 3110882
[No Abstract] [Full Text] [Related]
[Next] [New Search]
